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Abstract
Objective: Angiogenesis or neovascularization has long been known to aid in progression and metastasis of ma-
lignant tumors. Tumor angiogenesis is a complex event mediated by angiogenic factors released from cancer cells 
and or by host immune cells. Mast cells may induce tumor progression and potentiate metastasis by stimulating 
angiogenesis. The purpose of the present study was to validate topographic distribution of micro vessel density 
(MVD) and mast cell density (MCD) and help to elucidate the possible role of mast cells in tumor angiogenesis 
and correlating this with advanced disease parameters.                       
Study Design: MVD and MCD were investigated in tumor specimens from 30 patients diagnosed with different 
histologic grades of oral squamous cell carcinoma (OSCC). Intratumor vessels were stained with collagen Type 
IV antibody and mast cells with Toluidine blue before being measured by light microscopy.
Results: There was a significant correlation between MVD and disease progression and number of blood vessels 
increased from well to poorly differentiated OSCC where as MCD decreased. 
Conclusions: These findings suggest that angiogenesis indeed occur in OSCC and might be used as an index to 
inflect the aggression of the disease however mast cells make up only a part of complex process of angiogenesis 
along with other factors secreted by tumor. 
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Introduction
Oral Squamous Cell Carcinoma is the sixth most com-
mon cancer in the world and is one of the leading causes 
of death in India. Sixty percent of oral cancers are well 
advanced by the time they are detected and despite in-
novation being made in surgery, radiation and chemo-
therapy, the long term survival rate remains to be less 
than 50% (1). By the time oral cancer is diagnosed, most 
individuals have localized or regional disease (37% lo-
calized; 43% regional; 10% distant and 10% unstaged). 
Five year survival rates for all oral cancers cases are 79% 
for those with localized disease, 42% for regional disease 
and 19% for disease with distant metastases. Develop-
ment of oral cancer proceeds through discrete molecular 
genetic changes that are acquired from loss of genomic 
integrity following continued exposure to environmental 
risk factors (2). These genetic changes generate concomi-
tant phenotypic changes in the tumor cells allowing them 
to continually survive, spread out and having an ability to 
invade surrounding tissues and metastasize (3,4). 
Angiogenesis – the growth of new blood vessels from 
pre-existing ones is a complex phenomenon that is ab-
solutely required for the continued growth and survival 
of neoplasms (5). The growth of tumors beyond few 
millimeters depends on the establishment of microcir-
culation. The fact that tumors are angiogenesis depend-
ent and metastatic cells are only shed after the tumor 
establishes its microcirculation has been described in 
melanomas, breast carcinomas and other malignant ne-
oplasms (6). Angiogenesis as a central process in many 
human malignancies has been proposed to be regulated 
by a balance between angiogenic stimulators and inhi-
bitors (7). The “angiogenic switch” however depends on 
net balance of positive and negative angiogenic factors 
in the tumor. Thus, the angiogenic phenotype may result 
from the production of growth factors, such as FGF-2 
and VGEF, by the tumor cells and/or the down-regula-
tion of negative modulators, like TSP-1, in tissues with 
quiescent vasculature (8). The angiogenic phenotype in 
a tumor can be triggered by hypoxia resulting from the 
increasing distance of the growing tumor cells to the 
capillaries or from the inefficiency of the newly formed 
vessels. Also, several oncogenes such as V-ras, K-ras, 
v-raf,  src, fos and V-yes (9-11)  induce the up-regulation 
of angiogenic factors like VGEF and increase the pro-
duction of cytokines and proteolytic enzymes (12).
This complex event in addition to being mediated by an-
giogenic factors released from cancer cells also has the 
host contribution. Among the host immune cells, a role 
has been implicated for mast cells in tumor progression 
via promoting angiogenesis. The role of mast cells which 
are reservoirs of angiogenic peptides in neovasculariza-
tion is not clear. However mast cells products such as his-
tamine, basic fibroblast growth factor and heparin have 
been shown to promote tumor angiogenesis. Although 
mast cells (MCs) have been implicated in promoting an-
giogenesis in some malignant tumors, little is known in 
oral squamous cell carcinoma (OSCC) (13,14).
Studies on the topographical distribution of microvessel 
and mast cell hot spots might help elucidate the possible 
role of mast cells in tumor angiogenesis in OSCC. Thus the 
present study is focused at examining the microvessel den-
sity by employing type IV collagen a component of vessel 
wall in different histological grades of OSCC and to corre-
late angiogenesis with disease progression, and further to 
determine the role of mast cells in tumor  angiogenesis. 
Materials and Methods
-Tissue material
The material for the study included 30 formalin- fixed 
paraffin-embedded tissue blocks of histologically pro-
ven cases of OSCC from the archives of Department 
of Oral & Maxillofacial Pathology, Manipal College of 
Dental Sciences, Manipal, between the years 2003 and 
2006. Ten blocks of pyogenic granuloma and normal 
oral mucosa were used as controls. Immunohistochemi-
cal analysis using type IV collagen was done to assess 
the nature and distribution of blood vessels in different 
histological grades. Special stain Toludine blue for mast 
cells were carried out in all these cases.
MicroVessel Density (MVD)
The immunohistochemical analysis for blood vessel was 
performed using streptavidine- biotin-peroxidase tech-
nique. Paraffin- embedded tissues were cut into 4-µm- 
thick sections and taken onto poly -L- Lysine (Sigma 
Aldrich Chemical Co., St Louis, MO, USA) adhesive 
oated micro slides. The sections were brought to water, 
treated with xylene three times for 5 min and rehydrated 
with ethanol. Quenching of endogenous peroxidase ac-
tivity was achieved by immersing the slides in freshly 
prepared 3% H2O2 in methanol. For antigen retrieval, 
the sections were digested with 2mg/ml Pepsin in 0.1M 
HCl at room temperature for 30 mins, and then washed 
in distilled water. After a brief rinsing in phosphate 
buffered saline (PBS), sections were treated with 10% 
goat serum at room temperature for 30min to block any 
non-specific antigenic sites. The sections were then in-
cubated with primary antibody (anti collagen type IV 
Sigma Aldrich Chemical Co.) at 1:50 dilution, for 60 
minutes in a humid chamber. For reagent control, no 
primary antibody was added. After washing in PBS sec-
tions  were incubated with biotinylated secondary anti-
boby at 1:200 dilutions at room temperature for 30 min 
(Sigma Aldrich Chemical Co). Following a PBS wash 
for 5min thrice, sections were incubated with strepta-
vidin-peroxidase conjugate (Sigma Aldrich Chemical 
Co.), at a concentration of 1:200 for 30 min and detected 
using 0.05% 3,3-diaminobenzidine tetra-hydrochloride 
(DAB) (Dakocytomation, Glostrup, Denmark). The 
slides were counterstained with Meyer’s hematoxylin, 
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subsequent to which sections were dehydrated, cleared 
and mounted with DPX and cover slipped.
-Mast Cell Density (MCD)
In each of 30 cases, additional sections from the tissue 
blocks were taken and were stained with 0.1% aqueous 
Toluidine blue for observing the Mast cells in the tissue. 
The stain gave a light blue background to the section 
with mast cells appearing red-purple in color. This al-
lowed easy mapping of stained mast cells.  
-Evaluation
Evaluation of immune staining was performed by two 
observers. The initial evaluation was qualitative in order 
to examine the different expression pattern of the anti-
body. It was performed in all section. For quantitative 
analysis of Micro Vessel Density (MVD) the stained 
sections were screened at low power (4X) to identify the 
areas of highest vascularisation within the tumor (hot 
spots). Microvessel counts was performed in four fields 
at 10X magnification with the use of an ocular grid sub-
divided into 100 areas in four fields of vision, and for 
each field the hotspot MVD was noted. The blood ves-
sels were identified by presence of brown stained base-
ment membrane around them (Fig. 1.A). The vessel lu-
men, although usually present, was not a criterion used 
to define a microvessel, and red blood cells were not 
used to define vessel lumens. Partially identified ves-
sels, which were not totally contained in the field ana-
lysed, were not considered in vessel counts. 
Mast cells were identified by their characteristic meta-
chromasia. By using the same counting methods as for 
MVD, mast cells were counted in hot spots to determi-
nate the Mast Cell Density value.  
-Statistical Analysis
Microvessel density and Mast cell density was quantita-
tively assessed by two independent observers to remove 
any possible bias. Statistical analysis was performed us-
ing SPSS statistical software package version 15.0 (SPSS, 
Chicago). Non- parametric Mann-Whitney test was ap-
plied to statistically evaluate two group differences and 
Kruskal- wallis (ANOVA) test for three group differenc-
es. P-values of < 0.05 and < 0.001 were considered to be 
significant and very highly significant, respectively.
Results
-Microvessel Density
It was observed that all the 30 OSCC cases tested for 
the expression of Collagen IV, showed immunopositivi-
ty. Immunohistochemical staining of blood vessels with 
Collagen IV was within the basement membrane which 
stained positively. Intratumoral blood vessels concentrated 
in discrete hotspots both within sheets of tumor cells in 
carcinomas with a pushing margin and in areas containing 
leukocyte infiltration in carcinomas with an invasive mar-
gin (Fig. 1.B-D).  For quantitative analysis two observers 
independently counted the blood vessels within the tumor 
(hot spots) to minimize the subjective bias.
When the number of blood vessels were evaluated in 
well, moderately and poorly differentiated OSCCs, the 
mean number of blood vessels were found to be 51.55, 
90.15 and 164.25 respectively. Kruskal-wallis test (ANO-
VA) was applied on the results to compare the number of 
blood vessels in different grades of OSCCs, p value was 
found to be very highly significant (p= 0.001) (Table 1).
When the number of blood vessels were compared be-
tween the different grades of OSCC, well vs moderately 
differentiated – mean difference of 38.60 vessels was 
observed; well vs poorly differentiated – mean diffe-
rence of 112.70 vessels was observed; moderately vs 
poorly differentiated – mean difference of 74.10 vessels 
was observed.
These inter comparison results were assessed by Mann 
– Whitney U test. From these observations, it was im-
perative that p value was very highly significant in all 
the inter comparisons i.e. well vs moderately differenti-
ated (p = 0.001), well vs poorly differentiated (p=0.001) 
and moderately vs poorly differentiated (p= 0.001) (Ta-
ble 2). Hence, the number of blood vessels increased in 
transition from well differentiated to moderately diffe-
rentiated and from moderately differentiated to poorly 
differentiated OSCC (Fig. 2) (Table 2).
-Mast cell Density
By using the same counting methods as for blood ves-
sels, mast cells were counted in hot spots (Fig.1E, F). 
To eliminate the subjective bias, two observers inde-
pendently counted the mast cells. When the number 
of mast cells were evaluated in well, moderately and 
poorly differentiated OSCCs, the mean number of mast 
cells were found to be 12.85, 7.62 and 5.05 respectively. 
Kruskal-wallis test (ANOVA) was applied on the results 
to compare the number of mast cells in different grades 
of OSCCs, p value was found to be highly significant 
(p= 0.010) (Table 3).
When the number of mast cells was compared between 
Fig. 1. A. Shows type IV collagen immunopostivity in basement 
membrane around blood vessels located subepithelialy in normal 
mucosa (10X).
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the different grades of OSCC, well vs moderately differ-
entiated – mean difference of 5.225 cells were observed; 
well vs poorly differentiated – mean difference of 7.800 
cells were observed; moderately vs poorly differenti-
ated – mean difference of 2.575 cells was observed.
These inter comparison results when subjected to 
Mann – Whitney U test, p value was found to be not 
significant in the inter comparisons between well vs 
moderately differentiated (p = 0.064) and moderately 
vs poorly differentiated (p= 0.212). The p value was 
found to be highly significant in the inter comparision 
between well vs poorly differentiated (p=0.003) (Ta-
ble 4).  Hence, the number of mast cells decreased in 
transition from well differentiated to poorly differenti-
ated OSCC (Fig. 3) (Table 4). In the present study the 
Fig. 1. B. Shows circumferential arrangement of type IV collagen 
immunopositive blood vessels in Well Differentiated OSCC (25X).
Fig. 1. C. Shows an irregular arrangement blood vessels immunoposi-
tive for type IV collagen in Moderately Differentiated OSCC (25X).
Fig. 1. D. Shows an irregular arrangement of type IV collagen im-
munopositive blood vessels in Poorly Differentiated OSCC (25X).
Fig. 1. E. Shows Mast cells positive for toluidine blue in Well Dif-
ferentiated OSCC (40X).
Fig. 1. F. Shows Mast cells positive for Toluidine blue adjacent to 
tumor cells in OSCC (40X).
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Table 1. Micro vessel density (MVD) in different grades of OSCC.
MVD N MEAN Std Deviation H P 
Well 10 51.550 8.684  
Moderate 10 90.150 4.904 
Poor 10 164.250 20.326 25.818 0.001*
 * Shows very highly significant p-value (p < 0.001).
Fig. 2. WDSCC: Well differentiated squamous cell carcinoma.
MDSCC: Moderately differentiated squamous cell carcinoma.
PDSCC: Poorly differentiated squamous cell carcinoma.
Table 2. The comparison of micro vessel density (MVD) between 
different grades of OSCC.

Grade of OSCC Difference in count Z p 
Well
V/s
moderate
38.600 3.782 0.001* 
Well
V/s
poor
112.700 3.781 0.001* 
Moderate 
V/s
poor
74.100 3.781 0.001* 
Table 3. Mast cell density (MCD) in different grades of OSCC.
MCD N MEAN Std Deviation H P 
Well
Moderate 
Poor
10
10
10
12.850 
7.625 
5.050 
6.492 
5.389 
4.586 9.170 0.010** 

** Highly significant p-value (p < 0.05).
* Shows very highly significant p-value (p < 0.001).
Table 4. The comparison of MCD between different grades of 
OSCC.
Grade of OSCC Difference in count Z p 
Well
V/s
moderately
5.225 1.853 0.064#
Well
V/s
poorly
7.800 2.951 0.003** 
Moderately 
V/s
poorly
2.575 1.248 0.212#
 # Not significant (p- value > 0.05)
** Highly significant (p-value<0.05)
number of blood vessels increased from well to poorly 
differentiated showing an inverse relationship with the 
differentiation of the tumor. In contrast, the number of 
mast cells decreased from well differentiated to poorly 
differentiated OSCC.
Discussion
An adequate vascular response is essential for initial de-
velopment as well as continued growth of solid tumors. 
Experimental evidences suggest that tumor growth can 
be stunted by a variety of agents that have the ability to 
inhibit angiogenesis (5).
Currently, considerable attention has been focused on 
the mechanisms by which tumor acquire their blood 
supply for growth and dissemination. In the present 
study an increased angiogenesis was observed in diffe-
Fig. 3. WDSCC: Well differentiated squamous cell carcinoma.
MDSCC: Moderately differentiated squamous cell carcinoma.
PDSCC: Poorly differentiated squamous cell carcinoma.
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rent histological grades of OSCC with a different pattern 
of vascular organization. In well differentiated OSCC 
the vessels were arranged in a circumferential pattern 
located at the epithelial stromal interface; this induc-
tion of angiogenesis is probably mediated by specific 
angiogenic molecules released by the corresponding tu-
mor cells, which also reflects the potentially aggressive 
phenotype of the tumor. Supporting the observation of 
Hirakawa et al. (15) on cervical carcinomas which was 
associated with vascular cuffing in micro vessels in cer-
vical squamous epithelial lesions, further this pattern 
was related to local tumor invasion.
Studies have shown that the growth of the vessels ad-
jacent to the tumor cells increases the opportunity for 
tumor cells to enter the circulation (16). Alternatively 
a primary tumor containing a high proportion of an-
giogenic cells will seed into the blood stream which will 
then give rise to additional metastatic deposits thus am-
plifying the process of growth and dissemination. This 
has been explained by the fact that newly proliferating 
capillaries have fragmented basement membranes and 
are leaky, making them more accessible to tumor cells 
than mature vessels (17). The observation made in the 
present study in all the 10 cases of poorly differentiated 
OSCC and few cases of moderately differentiated OSCC 
suggest a change over to a highly angiogenic phenotype 
to cells, as well differentiated tumor progress to poorly 
differentiated tumor.
Another possibility which was taken into account was 
the contribution of stromal inflammation. The stromal 
tissue in OSCC is generally rich in inflammatory re-
action and focal aggregates of microvessels were seen 
to be associated with dense lymphoid infiltrate. The in-
flammatory cells are known to release angiogenic fac-
tors (18), however this view is still not clear whether 
they take any active part in tumor angiogenesis. Also 
the role of inflammatory cells in tumor stroma is contro-
versial, as accumulation of inflammatory cells at tumor 
site has been considered to be host defense mechanism. 
On the other hand, the presence of inflammatory cells 
in a tumor mass represents the basis of immunosurvil-
lence against tumor growth (19).  Recent studies indi-
cate that the inflammatory component of a developing 
neoplasm can provide useful means for cancer growth 
and metastasis mostly by potentiating extra cellular ma-
trix remodeling and angiogenesis (20,21).
Tumor angiogenesis is a complex event mediated by 
angiogenic factors released from cancer cells and or 
by host immune cells (18,22,23). Among the host im-
mune cells several observations have indicated the 
role of mast cells in tumor progression by promoting 
angiogenesis (22). In few malignancies large number 
of mast cell were detected before the occurrence of 
neovascularization (23). Basic FGF, IL 4, IL 8, TNF α, 
TNF β are among the mediators released by the gran-
ules of mast cells and are strong inducers of angiogen-
esis (24,25).
In the present study mast cells were counted in same 
areas as that of MVD in different grades of OSCC and 
it was found that there was a significant but inverse 
correlation between mast cell density and microvessel 
density. The number of mast cells decreased as the mi-
crovessel number increased.
These results are in contrast with the study done by Iama-
roon et al. (26) in 2003 in which they found that the densi-
ty of mast cells and microvessels appear to increase with 
the disease progression from normal oral mucosa, hy-
perkeratosis, premalignant dysplasia to invasive OSCC. 
Elpek et al. (14) in another study on squamous cell car-
cinoma of esophagus found a significant correlation be-
tween MVD and MCD values. Higher MVD and MCD 
values were also associated with tumor progression.
In the present study we found that the mast cell count 
decreased as the microvessel count increased with dise-
ase progression without any significant correlation be-
tween MVD and MCD. It is difficult to explain the dis-
cordant result with mast cell density in different grades 
of OSCC, hence it can be hypothesized that the lower 
density observed in all poorly differentiated OSCC is 
possibly due to the massive degranulation of mast cells 
making their identification difficult.
Reed et al. (27) found a significant increase in mast cell 
population surrounding melanocytic lesion expressing 
interleukin-3 (IL-3) compared with the lesion that did 
not express IL-3. In addition mast cells around these a-
reas were found to possess IL–3 alpha receptors. They 
concluded that the simultaneous expression of several 
substances providing mast cell chemotaxis in tumor 
cells could influence the degree of mast cell response 
and could define the presence of different types of mast 
cells containing specific receptors against these che-
moattractants. In agreement with previous studies, in 
the present study these differences in the type of mast 
cells could contribute to decrease count of mast cell 
during tumor progression.
It has been stated that the growth of solid tumor is 
dependent upon an adequate blood supply, which is 
achieved by generation of stroma, where the formation 
of new capillaries is a central event and also that this 
component is an entry site for immune inflammatory 
cells. In other words, in a particular tumor the number 
of microvessels and mast cells could be related to the 
amount of stromal component and consequently tu-
mor having more stroma might have more mast cells 
and microvessels (14). For this reason variation in the 
amount of stroma and tumor cells in different counting 
fields might influence the objectivity of the microvessel 
counting procedure.
In the present study the MCD decreased from well to 
poorly differentiated OSCC. Further studies with larger 
Med Oral Patol Oral Cir Bucal. 2012 Mar 1;17 (2):e190-6.                                                                                                                     Angiogenesis and mast cells in oral squamous cell carcinoma
e196
sample size are needed to establish relationship between 
angiogenesis and mast cells.
A variety of chemotherapeutic drugs being used to treat 
cancer hold limited efficacy, due to problems of deliv-
ery, penetration and a moderate degree of selectivity 
for the tumor cells, thereby causing severe damage to 
healthy tissues. In addition to this, tumor cells are a rap-
idly changing target because of their genetic instabil-
ity, heterogeneity and high rate of mutation, leading to 
selection and overgrowth of a drug- resistant tumor cell 
population (28,29).
Anti-angiogenic therapy, which targets activated en-
dothelial cells, offers several advantages over therapy 
directed against tumor cells. First, endothelial cells are 
a genetically stable, diploid and homogenous target and 
spontaneous mutation rarely occur. Also, the turnover 
of tumor endothelial cells may be 50 times higher than 
that of endothelium in normal quiescent tissues, and 
activated blood vessels express specific markers like 
integrin avb3, E-selectin, Tie and VGEF receptors. Be-
cause anti-angiogenic therapy is directed at activated 
endothelial cells, its target should be easily accessible 
by systemic administration. A number of angiogenesis 
inhibitors are being studied; among these are endosta-
tin, thalidomide, AE- 941(Neovastat), bevacizumab 
(also known as Avastin, anti-VEGF, RhuMabVEGF) 
and the arthritis medication celocoxib.
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